Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer, September 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 273 articles:
HTML format


 

Single Articles

  1. KULMANY AE, Frank E, Papp D, Szekeres A, et al
    Biological Evaluation of Antiproliferative and Anti-Invasive Properties of an Androstadiene Derivative on Human Cervical Cancer Cell Lines.
    J Steroid Biochem Mol Biol. 2021 Aug 31:105990. doi: 10.1016/j.jsbmb.2021.105990
    PubMed    
    Abstract available

  2. LI L, Xiao Y, Xu Z, Wang S, et al
    Zileuton inhibits arachidonate-5-lipoxygenase to exert antitumor effects in preclinical cervical cancer models.
    Cancer Chemother Pharmacol. 2021 Sep 3. pii: 10.1007/s00280-021-04343.
    PubMed    
    Abstract available

  3. YEA JW, Park JW, Oh SA, Park J, et al
    Chemoradiotherapy with hyperthermia versus chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysis.
    Int J Hyperthermia. 2021;38:1333-1340.
    PubMed    
    Abstract available

  4. BI Y, Wang Y, Zhang J, Shi X, et al
    Clinical outcomes of uterine arterial chemoembolization with drug-eluting beads for advanced-stage or recurrent cervical cancer.
    Abdom Radiol (NY). 2021 Sep 2. pii: 10.1007/s00261-021-03267.
    PubMed    
    Abstract available

  5. LI C, Li Y, Zhang Y, Yan H, et al
    Knockdown of LINC01123 inhibits cell viability, migration and invasion via miR-361-3p/TSPAN1 targeting in cervical cancer.
    Exp Ther Med. 2021;22:1184.
    PubMed    
    Abstract available

  6. ISONO R, Tsubamoto H, Inoue K, Ueda T, et al
    Itraconazole Increases Resolvin E3 Concentration and 12/15-lipoxygenase Inhibitor Attenuates Itraconazole Cytotoxicity in Cervical Cancer Cells.
    Anticancer Res. 2021;41:4271-4276.
    PubMed    
    Abstract available

  7. WU Z, Li T, Han Y, Jiang M, et al
    Development of models for cervical cancer screening: construction in a cross-sectional population and validation in two screening cohorts in China.
    BMC Med. 2021;19:197.
    PubMed    
    Abstract available

  8. ZHU L, Zhang L, Zhou M, Alifu N, et al
    [Application of organic fluorescent probe-assisted near infrared fluorescence imaging in cervical cancer diagnosis].
    Sheng Wu Gong Cheng Xue Bao. 2021;37:2678-2687.
    PubMed    
    Abstract available

  9. DIGNAN M, Kruse-Diehr A
    Increasing Cervical Cancer Prevention Through HPV Testing: Challenges in Developing Persuasive Messages.
    Cancer Prev Res (Phila). 2021;14:823-824.
    PubMed    
    Abstract available

  10. THEOBALD L, Stroeder R, Melchior P, Iordache II, et al
    Chemoradiotherapy-induced increase in Th17 cell frequency in cervical cancer patients is associated with therapy resistance and early relapse.
    Mol Oncol. 2021 Sep 1. doi: 10.1002/1878-0261.13095.
    PubMed    
    Abstract available

  11. THUMMADI NB, Mallikarjuna T, Vindal V, Manimaran P, et al
    Prioritizing the candidate genes related to cervical cancer using the moment of inertia tensor.
    Proteins. 2021 Sep 1. doi: 10.1002/prot.26226.
    PubMed    
    Abstract available

  12. CAO X, Ma Q, Wang B, Qian Q, et al
    Circ-E2F3 promotes cervical cancer progression by inhibiting microRNA-296-5p and increasing STAT3 nuclear translocation.
    Ann N Y Acad Sci. 2021 Sep 1. doi: 10.1111/nyas.14653.
    PubMed    
    Abstract available

  13. LI F, Liang Y, Ying P
    Knockdown of MIR93HG inhibits proliferation and promotes apoptosis of cervical cancer cells by miR498 via EP300.
    Mol Med Rep. 2021;24.
    PubMed    
    Abstract available

  14. BASSETTE E, Mabachi N, Kennedy M, Mendez-Puac F, et al
    Perceptions of Cervical Cancer Screening in Rural Guatemala.
    Hisp Health Care Int. 2021 Sep 1:15404153211024114.
    PubMed    
    Abstract available

  15. REN Z, Liu Z, Ma S, Yue J, et al
    Expression and clinical significance of UBE2V1 in cervical cancer.
    Biochem Biophys Rep. 2021;28:101108.
    PubMed    
    Abstract available

  16. HUANG C, Qin X, Zhao N, Jin H, et al
    Erratum: MicroRNA-100 functions as a tumor suppressor in cervical cancer via downregulating the SATB1 expression and regulating AKT/mTOR signaling pathway and epithelial-to-mesenchymal transition.
    Oncol Lett. 2021;22:741.
    PubMed    
    Abstract available

  17. DUAN Y, Chen L, Shao J, Jiang C, et al
    Lanatoside C inhibits human cervical cancer cell proliferation and induces cell apoptosis by a reduction of the JAK2/STAT6/SOCS2 signaling pathway.
    Oncol Lett. 2021;22:740.
    PubMed    
    Abstract available

  18. KHORRAMI S, Zamani H, Hasanzadeh M, Mehramiz M, et al
    Association of a genetic variant in Interleukin-10 gene with increased risk and inflammation associated with cervical cancer.
    Gene. 2021 Aug 28:145933. doi: 10.1016/j.gene.2021.145933.
    PubMed    
    Abstract available

  19. DE PAUW H, Donders G, Weyers S, De Sutter P, et al
    Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study.
    Arch Public Health. 2021;79:155.
    PubMed    
    Abstract available

  20. BAEZCONDE-GARBANATI L, Ochoa CY, Murphy ST, Moran MB, et al
    Open Versus Minimally Invasive Radical Trachelectomy in Early-Stage Cervical Cancer: International Radical Trachelectomy Assessment Study.
    Am J Obstet Gynecol. 2021 Aug 27. pii: S0002-9378(21)00963.
    PubMed    
    Abstract available

  21. KEDVES A, Gulyban A, Glavak C, Toller G, et al
    Retrospective validation of coverage probability based simultaneous integrated nodal boost in locally advanced cervical cancer: a mono-institutional analysis.
    Acta Oncol. 2021 Aug 30:1-4. doi: 10.1080/0284186X.2021.1971293.
    PubMed    


  22. CHEN J, Deng Y, Wang J, Chen S, et al
    Cyclometalated Ru(II) beta-carboline complexes induce cell cycle arrest and apoptosis in human HeLa cervical cancer cells via suppressing ERK and Akt signaling.
    J Biol Inorg Chem. 2021 Aug 30. pii: 10.1007/s00775-021-01894.
    PubMed    
    Abstract available

  23. O'CONNOR M, McSherry LA, Dombrowski SU, Francis JJ, et al
    Identifying ways to maximise cervical screening uptake: a qualitative study of GPs' and practice nurses' cervical cancer screening-related behaviours.
    HRB Open Res. 2021;4:44.
    PubMed    
    Abstract available

  24. SHIEH KR, Huang A, Xu Y
    Response to Immune Checkpoint Inhibitor Treatment in Advanced Cervical Cancer and Biomarker Study.
    Front Med (Lausanne). 2021;8:669587.
    PubMed    
    Abstract available

  25. YAN B, Dai X, Ma Q, Wu X, et al
    Stromal Neutrophil Extracellular Trap Density Is an Independent Prognostic Factor for Cervical Cancer Recurrence.
    Front Oncol. 2021;11:659445.
    PubMed    
    Abstract available

  26. MUNGMUNPUNTIPAMTIP R, Wiwanitkit V
    COVID-19 on cervical cancer screening.
    Eur J Cancer Prev. 2021 Aug 26. pii: 00008469-900000000-99022.
    PubMed    


  27. ARYA R, Giurcanu M, Jutzy JM, Peters P, et al
    Local Control and Use of External Beam Parametrial Boost in the Era of Image-Guided Brachytherapy for Locally Advanced Cervical Cancer.
    Am J Clin Oncol. 2021 Aug 30. pii: 00000421-900000000-98535.
    PubMed    
    Abstract available

  28. BEATY BT, Cosper PF, Beriwal S, Weiner AA, et al
    Why De-Intensification is not Possible in HPV-Associated Cervical Cancer.
    Semin Radiat Oncol. 2021;31:339-348.
    PubMed    


  29. BRAUN LA, Kostas-Polston EA, Miedema J, Hoffecker L, et al
    A Scoping Review of Cervical Cancer Risk Factors, Prevention, Diagnosis, and Treatment in U.S. Active Duty Military Women.
    Womens Health Issues. 2021;31 Suppl 1:S53-S65.
    PubMed    
    Abstract available

  30. MITRA T, Elangovan S
    Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.
    Mol Cell Biochem. 2021 Aug 28. pii: 10.1007/s11010-021-04249.
    PubMed    
    Abstract available

  31. SITLER C, Bunch KP, Padro D, Miller CR, et al
    Underserved Pacific Islanders With Locally Advanced Cervical Cancer Receive Higher Rates of Standard-of-Care Radiation Treatment Through the Pacific Island Health Care Project and Military Health System Compared to the Average U.S. Population.
    Mil Med. 2021 Aug 28. pii: 6358799. doi: 10.1093.
    PubMed    
    Abstract available

  32. ANJOS EFD, Martins PC, Prado NMBL, Bezerra VM, et al
    Quality of Actions to Control Cervical Cancer in Bahia, Brazil.
    Asian Pac J Cancer Prev. 2021;22:2343-2349.
    PubMed    
    Abstract available

  33. GOMES D, Silvestre S, Duarte AP, Venuti A, et al
    In Silico Approaches: A Way to Unveil Novel Therapeutic Drugs for Cervical Cancer Management.
    Pharmaceuticals (Basel). 2021;14.
    PubMed    
    Abstract available

  34. NJAGI SK, Ngure K, Mwaniki L, Kiptoo M, et al
    Prevalence and correlates of cervical squamous intraepithelial lesions among HIV-infected and uninfected women in Central Kenya.
    Pan Afr Med J. 2021;39:44.
    PubMed    
    Abstract available

  35. ZHU C, Zhang W, Wang X, Jiao L, et al
    Predictive value of preoperative serum squamous cell carcinoma antigen level for lymph node metastasis in early-stage cervical squamous cell carcinoma.
    Medicine (Baltimore). 2021;100:e26960.
    PubMed    
    Abstract available

  36. KIM YH, Lee SJ, Lee SU, Hwang IS, et al
    Primary signet ring cell carcinoma of the uterine cervix: A case report.
    Medicine (Baltimore). 2021;100:e26844.
    PubMed    
    Abstract available

  37. KARUNAKARAN V, Saritha VN, Ramya AN, Murali VP, et al
    Elucidating Raman Image-Guided Differential Recognition of Clinically Confirmed Grades of Cervical Exfoliated Cells by Dual Biomarker-Appended SERS-Tag.
    Anal Chem. 2021;93:11140-11150.
    PubMed    
    Abstract available

  38. AYESHA N, Aboulaghras S, Jahangeer M, Riasat A, et al
    Physiopathology and effectiveness of therapeutic vaccines against human papillomavirus.
    Environ Sci Pollut Res Int. 2021;28:47752-47772.
    PubMed    
    Abstract available

  39. BABI A, Issa T, Issanov A, Akilzhanova A, et al
    Prevalence of high-risk human papillomavirus infection among Kazakhstani women attending gynecological outpatient clinics.
    Int J Infect Dis. 2021;109:8-16.
    PubMed    
    Abstract available

  40. SHEJAWAL KP, Randive DS, Bhinge SD, Bhutkar MA, et al
    Green synthesis of silver, iron and gold nanoparticles of lycopene extracted from tomato: their characterization and cytotoxicity against COLO320DM, HT29 and Hella cell.
    J Mater Sci Mater Med. 2021;32:19.
    PubMed    
    Abstract available

  41. VAZIRI FARD E, Zhang S, El Achi HS, Covinsky M, et al
    Primary Synovial Sarcoma of the Uterine Cervix: First Case Report.
    Int J Gynecol Pathol. 2021;40:196-203.
    PubMed    
    Abstract available

  42. OU Z, Zhao D, Li B, Wang Y, et al
    A Preoperative Nomogram for Predicting Chemoresistance to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Squamous Carcinoma Treated with Radical Hysterectomy.
    Cancer Res Treat. 2021;53:233-242.
    PubMed    
    Abstract available

  43. ZHOU F, Marcus A
    Cervical Awareness Rabbit (CARA).
    Int J Surg Pathol. 2021;29:300.
    PubMed    


  44. MILLER EA, Pinsky PF
    Healthcare Access, Utilization, and Preventive Health Behaviors by Eligibility for Lung Cancer Screening.
    J Cancer Educ. 2021;36:330-337.
    PubMed    
    Abstract available

  45. LIU D, Ke J, Liu Y, Rao H, et al
    The interaction between PDCD4 and YB1 is critical for cervical cancer stemness and cisplatin resistance.
    Mol Carcinog. 2021 Sep 9. doi: 10.1002/mc.23345.
    PubMed    
    Abstract available

  46. CANFELL K, Smith MA, Bateson DJ
    Self-collection for HPV screening: a game changer in the elimination of cervical cancer.
    Med J Aust. 2021 Sep 9. doi: 10.5694/mja2.51262.
    PubMed    


  47. CASTLE PE, Einstein MH, Sahasrabuddhe VV
    Cervical cancer prevention and control in women living with human immunodeficiency virus.
    CA Cancer J Clin. 2021 Sep 9. doi: 10.3322/caac.21696.
    PubMed    
    Abstract available

  48. QU X, Shi Z, Guo J, Guo C, et al
    Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
    Cancer Med. 2021 Sep 8. doi: 10.1002/cam4.4054.
    PubMed    
    Abstract available

  49. XIAO L, Zhang S, Zheng Q, Zhang S, et al
    Dysregulation of KIF14 regulates the cell cycle and predicts poor prognosis in cervical cancer: a study based on integrated approaches.
    Braz J Med Biol Res. 2021;54:e11363.
    PubMed    
    Abstract available

  50. XUE P, Tang C, Jiang Y, Qiao YL, et al
    [Construction of an Information Platform for Cervical Cancer Prevention in the Digital Era].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021;43:649-652.
    PubMed    
    Abstract available

  51. CHEN H, Zhou J, Huang Q, Si MY, et al
    [Status of Human Papillomavirus Vaccination and Knowledge,Attitudes, and Influencing Factors towards Human Papillomavirus and Its Vaccines among University Students in Western China].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021;43:545-550.
    PubMed    
    Abstract available

  52. ROMERO SA, Pavan ICB, Morelli AP, Mancini MCS, et al
    Anticancer effects of root and beet leaf extracts (Beta vulgaris L.) in cervical cancer cells (HeLa).
    Phytother Res. 2021 Sep 8. doi: 10.1002/ptr.7255.
    PubMed    
    Abstract available

  53. DHANDAPANI H, Jayakumar H, Seetharaman A, Singh SS, et al
    Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4(+), CD8(+) T cells and activate NK cells: a potential candidate molecule for immunotherapy in cervical cancer.
    Cancer Cell Int. 2021;21:473.
    PubMed    
    Abstract available

  54. FENG W, Guo R, Zhang D, Zhang R, et al
    Circ-ABCB10 knockdown inhibits the malignant progression of cervical cancer through microRNA-128-3p/ZEB1 axis.
    Biol Proced Online. 2021;23:17.
    PubMed    
    Abstract available

  55. WILLIAMS J, Rakovac I, Victoria J, Tatarinova T, et al
    Cervical cancer testing among women aged 30-49 years in the WHO European Region.
    Eur J Public Health. 2021 Sep 7. pii: 6365774. doi: 10.1093.
    PubMed    
    Abstract available

  56. WU A, Lin L, Li X, Xu Q, et al
    Overexpression of ARHGAP30 suppresses growth of Cervical Cancer Cells by downregulating ribosome biogenesis.
    Cancer Sci. 2021 Sep 6. doi: 10.1111/cas.15130.
    PubMed    
    Abstract available

  57. AZAIS H, Canlorbe G, Uzan C, Belghiti J, et al
    ASO Author Reflection: Fertility-Sparing Surgery for Early-Stage Cervical Cancer-What Perspectives Between Oncological Prognosis and Obstetrical Future?
    Ann Surg Oncol. 2021 Sep 6. pii: 10.1245/s10434-021-10780.
    PubMed    


  58. LIU Z, Chen W, Guan H, Zhen H, et al
    An Adversarial Deep-Learning-Based Model for Cervical Cancer CTV Segmentation With Multicenter Blinded Randomized Controlled Validation.
    Front Oncol. 2021;11:702270.
    PubMed    
    Abstract available

  59. WANG D, Liu X, Wang W, Huo L, et al
    The Role of the Metabolic Parameters of (18)F-FDG PET/CT in Patients With Locally Advanced Cervical Cancer.
    Front Oncol. 2021;11:698744.
    PubMed    
    Abstract available

  60. FENG Q, Li S, Ma HM, Yang WT, et al
    LGR6 activates the Wnt/beta-catenin signaling pathway and forms a beta-catenin/TCF7L2/LGR6 feedback loop in LGR6(high) cervical cancer stem cells.
    Oncogene. 2021 Sep 6. pii: 10.1038/s41388-021-02002.
    PubMed    
    Abstract available

  61. PAPPA KI, Daskalakis G, Anagnou NP
    Metabolic rewiring is associated with HPV-specific profiles in cervical cancer cell lines.
    Sci Rep. 2021;11:17718.
    PubMed    
    Abstract available

  62. HUANG X, Fang M, Zhu L, Gu C, et al
    Clinical Observation of Prophylactic Extended-Field Intensity-Modulated Radiation Therapy with Synchronous Chemotherapy in Locally Advanced Cervical Cancer.
    Med Sci Monit. 2021;27:e930457.
    PubMed    
    Abstract available

  63. BREBAN-KEHL M, Zaccarini F, Sanson C, Maulard A, et al
    [Fertility preservation in cervical cancer, analysis of 30 years of practice and immersion in future developments.]
    Gynecol Obstet Fertil Senol. 2021 Sep 3. pii: S2468-7189(21)00211.
    PubMed    
    Abstract available

  64. TATARINOVA TA
    [The morbidity and mortality of cervix cancer in The Russian Federation in 2007-2018].
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2021;29:892-897.
    PubMed    
    Abstract available

  65. SENKOMAGO V, Greek A, Jackson JE, Thomas CC, et al
    Learning From Cervical Cancer Survivors: An Examination of Barriers and Facilitators to Cervical Cancer Screening Among Women in the United States.
    J Prim Care Community Health. 2021;12:21501327211041862.
    PubMed    
    Abstract available

  66. XU Z, Zhang Y, Ocansey DKW, Wang B, et al
    Glycosylation in Cervical Cancer: New Insights and Clinical Implications.
    Front Oncol. 2021;11:706862.
    PubMed    
    Abstract available

  67. LI H, Zhu M, Jian L, Bi F, et al
    Radiomic Score as a Potential Imaging Biomarker for Predicting Survival in Patients With Cervical Cancer.
    Front Oncol. 2021;11:706043.
    PubMed    
    Abstract available

  68. METZLER JM, Schaer G, Imesch P
    First case of four spontaneously conceived successful pregnancies after fertility-sparing surgery for cervical cancer.
    Clin Case Rep. 2021;9:e04534.
    PubMed    
    Abstract available

  69. CHEN W, Huang S, Shi K, Yi L, et al
    Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis.
    Cancer Control. 2021;28:10732748211033743.
    PubMed    
    Abstract available

  70. CHEN L, Zhong Y, Yang X, Zhang Q, et al
    Downregulation of GTSE1 leads to the inhibition of proliferation, migration, and Warburg effect in cervical cancer by blocking LHDA expression.
    J Obstet Gynaecol Res. 2021 Sep 5. doi: 10.1111/jog.15000.
    PubMed    
    Abstract available

  71. MUN J, Park SJ, Yim GW, Chang SJ, et al
    Solution to prevent tumor spillage in minimally invasive radical hysterectomy using the endoscopic stapler for treating early-stage cervical cancer: Surgical technique with video.
    J Gynecol Obstet Hum Reprod. 2021;50:102211.
    PubMed    
    Abstract available

  72. HE H, Zheng C, Tang Y
    Overexpression of SMC4 predicts a poor prognosis in cervical cancer and facilitates cancer cell malignancy phenotype by activating NF-kappaB pathway.
    Hum Cell. 2021 Sep 3. pii: 10.1007/s13577-021-00603.
    PubMed    
    Abstract available

  73. XU F, Zhang F, Wang Q, Xu Y, et al
    The augment of regulatory T cells undermines the efficacy of anti-PD-L1 treatment in cervical cancer.
    BMC Immunol. 2021;22:60.
    PubMed    
    Abstract available

  74. BAEZCONDE-GARBANATI L, Ochoa CY, Murphy ST, Moran MB, et al
    Carcinomatous meningitis from recurrent glassy cell carcinoma of the uterine cervix-A case report.
    J Obstet Gynaecol Res. 2021;47:3396-3400.
    PubMed    
    Abstract available

  75. LI Y, Tang Y, Li Z, Hou G, et al
    CircSOS2 promotes cervical squamous cell carcinoma by regulation of proliferation, cell cycle, apoptosis, migration, invasion, and glycolysis by targeting miR-543/FNDC3B axis.
    Arch Biochem Biophys. 2021;708:108925.
    PubMed    
    Abstract available

  76. MCGAURAN MFG, Pendlebury AB, Hiscock RJ, Lamont JM, et al
    Possible high-grade squamous intraepithelial lesion (pHSIL) in the new cervical screening paradigm: The outcomes and the role of clinicopathological review.
    Aust N Z J Obstet Gynaecol. 2021;61:569-575.
    PubMed    
    Abstract available

  77. JEGATHEES S, Mac OA, Dodd RH
    No longer recommended for cervical screening: How women aged 18-24 feel about the renewed National Cervical Screening Program.
    Aust N Z J Obstet Gynaecol. 2021;61:576-584.
    PubMed    
    Abstract available

  78. BELLO-RIOS C, Montano S, Garibay-Cerdenares OL, Araujo-Arcos LE, et al
    Modeling and Molecular Dynamics of the 3D Structure of the HPV16 E7 Protein and Its Variants.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  79. YOSHIDA H, Naka T, Kobayashi-Kato M, Kikkawa N, et al
    Gastric-type cervical adenocarcinoma with squamous differentiation: buried in adenosquamous carcinomas?
    Virchows Arch. 2021;479:407-412.
    PubMed    
    Abstract available

  80. DU H, Duan X, Liu Y, Shi B, et al
    Evaluation of Cobas HPV and SeqHPV Assays in the Chinese Multicenter Screening Trial.
    J Low Genit Tract Dis. 2021;25:22-26.
    PubMed    
    Abstract available

  81. UPADHYAY BASKOTA S, Wang T, Zhao C
    Follow-up Findings in Postconservative Treatment Surveillance for Women With Cervical Adenocarcinoma In Situ.
    J Low Genit Tract Dis. 2021;25:38-42.
    PubMed    
    Abstract available

  82. SEOW DYB, Busmanis I
    Persistent vaginal melanoma as an unusual mimic in the endocervix.
    Pathology. 2021;53:552-555.
    PubMed    


  83. RODRIGUEZ SA, Higashi RT, Betts AC, Ortiz C, et al
    Anal Cancer and Anal Cancer Screening Knowledge, Attitudes, and Perceived Risk Among Women Living With HIV.
    J Low Genit Tract Dis. 2021;25:43-47.
    PubMed    
    Abstract available

  84. SAYED SA, Naugler C, Chen G, Dickinson JA, et al
    Cervical Screening Practices and Outcomes for Young Women in Response to Changed Guidelines in Calgary, Canada, 2007-2016.
    J Low Genit Tract Dis. 2021;25:1-8.
    PubMed    
    Abstract available

  85. BONDE J, Bottari F, Iacobone AD, Cocuzza CE, et al
    Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review.
    J Low Genit Tract Dis. 2021;25:27-37.
    PubMed    
    Abstract available

  86. ZHENG Z, He Q, An L, Li D, et al
    HLA Class II alleles and association with HPV Infection prevalence in high-risk HPV-positive Han women in southern China.
    Infect Dis Now. 2021;51:67-70.
    PubMed    
    Abstract available

  87. KUNOS CA
    Novel Radiosensitization Strategies in Uterine Cervix Cancer.
    Semin Radiat Oncol. 2020;30:281-290.
    PubMed    
    Abstract available

  88. AUGUSTE P
    Cervical Cancer Screening: Updated Guidelines from the American Cancer Society.
    Am Fam Physician. 2021;104:314-315.
    PubMed    
    Abstract available

  89. CHEN R, Sheng C, Ma R, Zhang L, et al
    PLAC1 is an independent predictor of poor survival, and promotes cell proliferation and invasion in cervical cancer.
    Mol Med Rep. 2021;24.
    PubMed    
    Abstract available

  90. AHN SY, Song J, Kim YC, Kim MH, et al
    Mitofusin-2 Promotes the Epithelial-Mesenchymal Transition-Induced Cervical Cancer Progression.
    Immune Netw. 2021;21:e30.
    PubMed    
    Abstract available

  91. AL-SAADI AN, Al-Muqbali AH, Dawi E
    Women's Knowledge of Cervical Cancer: A cross-sectional study in Al Buraimi Governorate, Oman.
    Sultan Qaboos Univ Med J. 2021;21:450-456.
    PubMed    
    Abstract available

  92. JIANG Y, Yuan Y, Chen M, Li S, et al
    PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression.
    Theranostics. 2021;11:9162-9176.
    PubMed    
    Abstract available

  93. CHAPOLA J, Lee F, Bula A, Mapanje C, et al
    Barriers to follow-up after an abnormal cervical cancer screening result and the role of male partners: a qualitative study.
    BMJ Open. 2021;11:e049901.
    PubMed    
    Abstract available


  94. Retraction of: miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1 (doi: 10.1089/cbr.2019.2983).
    Cancer Biother Radiopharm. 2021 Aug 12. doi: 10.1089/cbr.2019.2983.
    PubMed    



  95. Retraction of: MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells (doi: 10.1089/cbr.2019.2858).
    Cancer Biother Radiopharm. 2021 Aug 12. doi: 10.1089/cbr.2019.2858.
    PubMed    


  96. DU J, Song D, Cao T, Li Y, et al
    Saikosaponin-A induces apoptosis of cervical cancer through mitochondria- and endoplasmic reticulum stress-dependent pathway in vitro and in vivo: involvement of PI3K/AKT signaling pathway.
    Cell Cycle. 2021 Sep 14:1-12. doi: 10.1080/15384101.2021.1974791.
    PubMed    
    Abstract available

  97. BAIN E, Coleridge SL, Morrison J
    Small cell neuroendocrine tumour of the cervix in pregnancy: the importance of multidisciplinary management.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  98. AKIMENKO VV, Adi-Kusumo F
    Stability analysis of an age-structured model of cervical cancer cells and HPV dynamics.
    Math Biosci Eng. 2021;18:6155-6177.
    PubMed    
    Abstract available

  99. HUANG ZY, Liao PJ, Liu YX, Zhong M, et al
    Protein tyrosine phosphatase, receptor type B is a potential biomarker and facilitates cervical cancer metastasis via epithelial-mesenchymal transition.
    Bioengineered. 2021;12:5739-5748.
    PubMed    
    Abstract available

  100. AREKLETT EW, Fagereng E, Bruheim K, Andersson S, et al
    Self-reported cognitive impairment in cervical cancer survivors: A cross-sectional study.
    Psychooncology. 2021 Sep 13. doi: 10.1002/pon.5818.
    PubMed    
    Abstract available

  101. PUNCHOO R, Zhou E, Bhoora S
    Flow Cytometric Analysis of Apoptotic Biomarkers in Actinomycin D-treated SiHa Cervical Cancer Cells.
    J Vis Exp. 2021;.
    PubMed    
    Abstract available

  102. RAMIREZ MARTINEZ ND, Gallegos Garcia V, Gaytan Hernandez D, Zermeno Ugalde P, et al
    [Phase angle assessment by electrical vector bioimpedance in women with cervical cancer].
    Nutr Hosp. 2021 Sep 13. doi: 10.20960/nh.03492.
    PubMed    
    Abstract available

  103. LI R, Song Y, Chen X, Chu M, et al
    METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE.
    Mol Ther Oncolytics. 2021;22:245-255.
    PubMed    
    Abstract available

  104. LI L, Ma Y, Maerkeya K, Reyanguly D, et al
    LncRNA OIP5-AS1 Regulates the Warburg Effect Through miR-124-5p/IDH2/HIF-1alpha Pathway in Cervical Cancer.
    Front Cell Dev Biol. 2021;9:655018.
    PubMed    
    Abstract available

  105. HU Y, Ma Y, Luo G, Liao W, et al
    Effect of MiR-375 Regulates YAP1 on the Invasion, Apoptosis, and Epithelial-Mesenchymal Transition of Cervical Cancer HeLa Cells.
    Evid Based Complement Alternat Med. 2021;2021:3088723.
    PubMed    
    Abstract available

  106. CHEN P, Gao Y, Ouyang S, Wei L, et al
    Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer.
    Front Pharmacol. 2021;12.
    PubMed    
    Abstract available

  107. KABANDA R, Bikaitwoha Maniple E, Baluku JB, Kiconco A, et al
    Utilisation of Community Audio Towers in Health Education for Prevention of Cervical Cancer by Health Workers in Kyotera District, Uganda: A Cross-Sectional Study.
    Risk Manag Healthc Policy. 2021;14:3667-3673.
    PubMed    
    Abstract available

  108. YANG Z, Liu H, Song R, Lu W, et al
    Reduced MAGI3 level by HPV18E6 contributes to Wnt/beta-catenin signaling activation and cervical cancer progression.
    FEBS Open Bio. 2021 Sep 12. doi: 10.1002/2211-5463.13298.
    PubMed    
    Abstract available

  109. ZHANG J, Liu HL, Liu JB, Zhang Y, et al
    LncRNA AL592284.1 facilitates proliferation and metastasis of cervical cancer cells via miR-30a-5p/Vimentin/EMT axis.
    Biochem Biophys Res Commun. 2021;577:95-102.
    PubMed    
    Abstract available

  110. MURILLO R, Gamboa O, Hernandez G, Gonzalez M, et al
    Accuracy of combined molecular and morphology-based triage for HPV-positive women in routine cervical cancer screening services from Colombia.
    Prev Med. 2021 Sep 8:106801. doi: 10.1016/j.ypmed.2021.106801.
    PubMed    
    Abstract available

  111. MILLER DL, Graham A, Davis KE, Kaur H, et al
    Risk Assessment of Human Papillomavirus-Positive Cytology-Negative Cervical Cancer Screening in Black and White Women.
    Am J Clin Pathol. 2021 Sep 11. pii: 6368701. doi: 10.1093.
    PubMed    
    Abstract available

  112. OJHA N, Jha M, Shrestha E, Dangal G, et al
    Late Stage Cervical Cancer among Confirmed Cervical Cancer Cases in a Tertiary Care Centre: A Descriptive Cross-sectional Study.
    JNMA J Nepal Med Assoc. 2021;59:630-634.
    PubMed    
    Abstract available

  113. BHAGAT B, Aacharya BC, Gurung S, Bhatta RR, et al
    Carcinosarcoma of the Cervix: A Case Report.
    JNMA J Nepal Med Assoc. 2021;59:814-817.
    PubMed    
    Abstract available

  114. TUNG HJ, Wang CC, Liu FY, Lai CH, et al
    Complete remission of advanced and recurrent cervical cancer with pembrolizumab treatment- 3 case reports.
    Taiwan J Obstet Gynecol. 2021;60:938-941.
    PubMed    
    Abstract available

  115. LOCKLAR LRB, Do DP
    Rural-urban differences in HPV testing for cervical cancer screening.
    J Rural Health. 2021 Sep 10. doi: 10.1111/jrh.12615.
    PubMed    
    Abstract available

  116. CHOPRA S, Gupta S, Kannan S, Dora T, et al
    Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial.
    J Clin Oncol. 2021 Sep 10:JCO2002530. doi: 10.1200/JCO.20.02530.
    PubMed    
    Abstract available

  117. GOMES MLS, Vieira NFC, Sousa DMDN, Moura NDS, et al
    Health outcomes in women attending with clinical guideline PROGYNE to a primary care center for cervical cancer prevention.
    J Obstet Gynaecol Res. 2021 Sep 9. doi: 10.1111/jog.15017.
    PubMed    
    Abstract available

  118. SHIN JW, Kim SH, Yoon JY
    PTEN downregulation induces apoptosis and cell cycle arrest in uterine cervical cancer cells.
    Exp Ther Med. 2021;22:1100.
    PubMed    
    Abstract available

  119. LI X, Qu LX, Ren YM, Hu C, et al
    Case Report: A Case Report and Literature Review on Severe Bullous Skin Reaction Induced by anti-PD-1 Immunotherapy in a Cervical Cancer Patient.
    Front Pharmacol. 2021;12:707967.
    PubMed    
    Abstract available

  120. SPENCER JC, Brewer NT, Coyne-Beasley T, Trogdon JG, et al
    Reducing Poverty-Related Disparities in Cervical Cancer: The Role of HPV Vaccination.
    Cancer Epidemiol Biomarkers Prev. 2021 Sep 9. pii: 1055-9965.EPI-21-0307.
    PubMed    
    Abstract available

  121. LV L, Wang X
    MicroRNA-296 Targets Specificity Protein 1 to Suppress Cell Proliferation and Invasion in Cervical Cancer [Oncology Research 26(5) (2018) 775783].
    Oncol Res. 2021;28:835.
    PubMed    


  122. TANAKA T, Nishie R, Ueda S, Miyamoto S, et al
    Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  123. LOFTERS A, Devotta K, Prakash V, Vahabi M, et al
    Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  124. ROSELER J, Wolff R, Bauerschlag DO, Maass N, et al
    Challenges and Controversies in the Surgical Treatment of Cervical Cancer: Open Radical Hysterectomy versus Minimally Invasive Radical Hysterectomy.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  125. SHEN MM, Ge QY, Xu Y, Song GX, et al
    [Clinical and molecular pathological study of cervical adenocarcinoma with invasive micropapillary feature of five cases].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:1045-1047.
    PubMed    


  126. LYU BJ, Shi HY, Shao Y, Liu Q, et al
    [Endocervical adenocarcinomas classified by International Endocervical Adenocarcinoma Criteria and Classification: a clinicopathological and prognostic analysis of 286 cases].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:1014-1019.
    PubMed    
    Abstract available

  127. MOHOSHO MM
    HIV prevalence in patients with cervical carcinoma: A cohort study at a secondary hospital in South Africa.
    Medicine (Baltimore). 2021;100:e27030.
    PubMed    
    Abstract available

  128. SPAYNE J, Hesketh T
    Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators.
    BMJ Open. 2021;11:e052016.
    PubMed    
    Abstract available

  129. CARUSO G, Palaia I, DI Donato V, Pernazza A, et al
    Radical Surgery After Neoadjuvant Chemotherapy for Locally Advanced Neuroendocrine Cancer of the Cervix.
    Anticancer Res. 2021;41:4431-4438.
    PubMed    
    Abstract available

  130. BAEZCONDE-GARBANATI L, Ochoa CY, Murphy ST, Moran MB, et al
    Interaction between SCP3 and JAB1 Confers Cancer Therapeutic Resistance and Stem-like Properties through EGF Expression.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  131. WANG W, Liu Y, Pu Y, Li C, et al
    Effectiveness of focused ultrasound for high risk human papillomavirus infection-related cervical lesions.
    Int J Hyperthermia. 2021;38:96-102.
    PubMed    
    Abstract available

  132. YAGI A, Ueda Y, Nakagawa S, Masuda T, et al
    A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan.
    Cancer Sci. 2021;112:3691-3698.
    PubMed    
    Abstract available

  133. GALIARDI-CAMPOY AEB, Machado FC, Carvalho T, Tedesco AC, et al
    Effects of photodynamic therapy mediated by emodin in cervical carcinoma cells.
    Photodiagnosis Photodyn Ther. 2021;35:102394.
    PubMed    
    Abstract available

  134. LEE CY, Tseng CJ, Chang CC, Lee MC, et al
    Postpartum HPV Vaccination Rate and Differences in Background Characteristics Between HPV Vaccinated and Unvaccinated Postpartum Women: Strict Monitoring and Follow-Up of Postpartum HPV Vaccination Program.
    Front Immunol. 2021;12:626582.
    PubMed    
    Abstract available

  135. SHAO J, Shi G, Qi Z, Zheng J, et al
    Advancements in the Application of Ultrasound Elastography in the Cervix.
    Ultrasound Med Biol. 2021;47:2048-2063.
    PubMed    
    Abstract available

  136. BOKAN T, Ivanus U, Jerman T, Takac I, et al
    Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Radiol Oncol. 2021;55:187-195.
    PubMed    
    Abstract available

  137. LUKIC A, Rossi S, Frega A, Ruscito I, et al
    Prognostic role of immunohistochemical overexpression of the p16 protein in women under the age of 35 and diagnosed with HSIL (CIN2) subjected to "cervix sparing" excision.
    Eur Rev Med Pharmacol Sci. 2021;25:1261-1273.
    PubMed    
    Abstract available

  138. CARARO-LOPES E, Dias MH, da Silva MS, Zeidler JD, et al
    Autophagy buffers Ras-induced genotoxic stress enabling malignant transformation in keratinocytes primed by human papillomavirus.
    Cell Death Dis. 2021;12:194.
    PubMed    
    Abstract available

  139. PENG S, Ferrall L, Gaillard S, Wang C, et al
    Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
    mBio. 2021;12.
    PubMed    
    Abstract available

  140. TAKAKO K, Hoang L, Terinte C, Pesci A, et al
    Trefoil Factor 2 (TFF2) as a Surrogate Marker for Endocervical Gastric-type Carcinoma.
    Int J Gynecol Pathol. 2021;40:65-72.
    PubMed    
    Abstract available

  141. KAWASHITA S, Matsuda K, Matsuwaki T, Kurohama H, et al
    Cervical Superficially Invasive Squamous Cell Carcinoma With Supraclavicular Lymph Node Metastasis: A Case Report.
    Int J Gynecol Pathol. 2021;40:78-83.
    PubMed    
    Abstract available

  142. PANTANO NP, Fregnani JH, Resende JC, Zeferino LC, et al
    Evaluation of human papillomavirus self-collection offered by community health workers at home visits among under-screened women in Brazil.
    J Med Screen. 2021;28:163-168.
    PubMed    
    Abstract available

  143. LIU Z, Liao Z, Chen Y, Zhou L, et al
    Research on CRISPR/system in major cancers and its potential in cancer treatments.
    Clin Transl Oncol. 2021;23:425-433.
    PubMed    
    Abstract available

  144. NOLAN TS, Tan A, Williams KP
    The ties that bind: Cancer history, communication, and screening intention associations among diverse families.
    J Med Screen. 2021;28:108-113.
    PubMed    
    Abstract available

  145. CASTANON A
    Technological advances: Have they improved standards? Review of outcomes from the Welsh cervical screening programme.
    J Med Screen. 2021;28:80-87.
    PubMed    
    Abstract available

  146. WILSON E, Barnard S, Mahmood S, Nuccio O, et al
    Experiences of a 'screen and treat' cervical cancer prevention programme among brothel-based female sex workers in Bangladesh: A qualitative interview study.
    Womens Health (Lond). 2021;17:17455065211047772.
    PubMed    
    Abstract available

  147. LI Y, Song X, Liu L, Yue L, et al
    NUAK2 silencing inhibits the proliferation, migration and epithelialtomesenchymal transition of cervical cancer cells via upregulating CYFIP2.
    Mol Med Rep. 2021;24.
    PubMed    
    Abstract available

  148. DING B, Guan X, Duan K, Shen Y, et al
    Laparoscopic radical hysterectomy with enclosed colpotomy without the use of uterine manipulator for early-stage cervical cancer.
    J Minim Access Surg. 2021;17:570-572.
    PubMed    
    Abstract available

  149. DIELEMAN M, de Waard J, Wisman GBA, Schuuring E, et al
    Preferences and Experiences Regarding the Use of the Self-Sampling Device in hrHPV Screening for Cervical Cancer.
    Patient. 2021 Sep 24. pii: 10.1007/s40271-021-00550.
    PubMed    
    Abstract available

  150. IVANUS U, Jerman T, Gasper Oblak U, Meglic L, et al
    The impact of the COVID-19 pandemic on organised cervical cancer screening: The first results of the Slovenian cervical screening programme and registry.
    Lancet Reg Health Eur. 2021;5:100101.
    PubMed    
    Abstract available

  151. LI P, Liu J, Wang L, Kang S, et al
    The Effect of Laparoscopic Radical Hysterectomy Surgical Volume on Oncology Outcomes in Early-Stage Cervical Cancer.
    Front Surg. 2021;8:692163.
    PubMed    
    Abstract available

  152. HE Z, Wang X, Yang Z, Jiang Y, et al
    Expression and prognosis of CDC45 in cervical cancer based on the GEO database.
    PeerJ. 2021;9:e12114.
    PubMed    
    Abstract available

  153. WANG S, Wang HJ, Li L, Yang J, et al
    Comparison of different HPV-based strategies and cytology in routine cervical cancer screening programme in China: a population-based study.
    Cancer Prev Res (Phila). 2021 Sep 23. pii: 1940-6207.CAPR-21-0104.
    PubMed    
    Abstract available

  154. HAHN EE, Munoz-Plaza C, Altman DE, Hsu C, et al
    De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening.
    Implement Sci Commun. 2021;2:108.
    PubMed    
    Abstract available

  155. PEDONE ANCHORA L, Bizzarri N, Gallotta V, Chiantera V, et al
    Impact of surgeon learning curve in minimally invasive radical hysterectomy on early stage cervical cancer patient survival.
    Facts Views Vis Obgyn. 2021;13:233-244.
    PubMed    
    Abstract available

  156. OKUNADE KS, Soibi-Harry A, John-Olabode S, Adejimi AA, et al
    Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial.
    JCO Glob Oncol. 2021;7:1418-1425.
    PubMed    
    Abstract available

  157. NATH N, Rana A, Nagini S, Mishra R, et al
    Glycogen synthase kinase-3beta inactivation promotes cervical cancer progression, invasion, and drug resistance.
    Biotechnol Appl Biochem. 2021 Sep 23. doi: 10.1002/bab.2258.
    PubMed    
    Abstract available

  158. SUVANNASARN R, Muangmool T, Wongpakaran N, Charoenkwan K, et al
    Health-related quality of life for early-stage cervical cancer survivors after primary radical surgery followed by radiotherapy versus radical surgery alone.
    J Obstet Gynaecol. 2021 Sep 23:1-8. doi: 10.1080/01443615.2021.1945013.
    PubMed    
    Abstract available

  159. DUCRAY JF, Kell CM, Basdav J, Haffejee F, et al
    Cervical cancer knowledge and screening uptake by marginalized population of women in inner-city Durban, South Africa: Insights into the need for increased health literacy.
    Womens Health (Lond). 2021;17:17455065211047141.
    PubMed    
    Abstract available

  160. TANG Y, Zhang AXJ, Chen G, Wu Y, et al
    Prognostic and therapeutic TILs of cervical cancer-Current advances and future perspectives.
    Mol Ther Oncolytics. 2021;22:410-430.
    PubMed    
    Abstract available

  161. LU X, Song X, Hao X, Liu X, et al
    miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway.
    Bioengineered. 2021;12:7079-7092.
    PubMed    
    Abstract available

  162. GUZEL C, van Sten-Van't Hoff J, de Kok IMCM, Govorukhina NI, et al
    Molecular markers for cervical cancer screening.
    Expert Rev Proteomics. 2021 Sep 23. doi: 10.1080/14789450.2021.1980387.
    PubMed    
    Abstract available

  163. LUO Y, Li Y, Ge P, Zhang K, et al
    QKI-Regulated Alternative Splicing Events in Cervical Cancer: Pivotal Mechanism and Potential Therapeutic Strategy.
    DNA Cell Biol. 2021 Sep 22. doi: 10.1089/dna.2021.0069.
    PubMed    
    Abstract available

  164. BOYCE-FAPPIANO D, Nguyen KA, Gjyshi O, Manzar G, et al
    Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.
    JCO Oncol Pract. 2021 Sep 22:OP2100291. doi: 10.1200/OP.21.00291.
    PubMed    
    Abstract available

  165. LI M, Tian X, Guo H, Xu X, et al
    A novel lncRNA-mRNA-miRNA signature predicts recurrence and disease-free survival in cervical cancer.
    Braz J Med Biol Res. 2021;54:e11592.
    PubMed    
    Abstract available

  166. CALDERON-MORA J, Alomari A, Byrd TL, Shokar NK, et al
    Evaluation of a Narrative Video to Promote Prevention and Early Detection of Cervical Cancer Among Latinas.
    Health Promot Pract. 2021 Sep 22:15248399211038943.
    PubMed    
    Abstract available

  167. INDRACANTI M, Berhane N, Minyamer T
    Factors Associated with Pre- and Post-Educational Intervention Knowledge Levels of HPV and Cervical Cancer Among the Male and Female University Students, Northwest Ethiopia.
    Cancer Manag Res. 2021;13:7149-7163.
    PubMed    
    Abstract available

  168. PERGIALIOTIS V, Bellos I, Douligeris A, Thomakos N, et al
    The impact of adjuvant hysterectomy on survival outcomes of patients with locally advanced cervical cancer: A network meta-analysis.
    Eur J Surg Oncol. 2021 Sep 16. pii: S0748-7983(21)00734.
    PubMed    
    Abstract available

  169. HUANG SS, Sui L, Chen LM, Zhang HW, et al
    [Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].
    Zhonghua Fu Chan Ke Za Zhi. 2021;56:622-629.
    PubMed    
    Abstract available

  170. MUNSHI VN, Perkins RB, Sy S, Kim JJ, et al
    Cost-effectiveness Analysis of the 2019 ASCCP Risk-Based Management Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
    Am J Obstet Gynecol. 2021 Sep 18. pii: S0002-9378(21)01009.
    PubMed    
    Abstract available

  171. PAN Q, Meng X, Li J, Qin X, et al
    CircSAMD11 facilitates progression of cervical cancer via regulating miR-503/SOX4 axis through Wnt/beta-catenin pathway.
    Clin Exp Pharmacol Physiol. 2021 Sep 21. doi: 10.1111/1440-1681.13593.
    PubMed    
    Abstract available

  172. EJEGOD DM, Pedersen H, Pedersen BT, Jonassen CM, et al
    Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program.
    Am J Clin Pathol. 2021 Sep 21. pii: 6373362. doi: 10.1093.
    PubMed    
    Abstract available

  173. BAIOCCHI G, Ribeiro R, Dos Reis R, Falcao DF, et al
    Open Versus Minimally Invasive Radical Hysterectomy in Cervical Cancer: The CIRCOL Group Study.
    Ann Surg Oncol. 2021 Sep 20. pii: 10.1245/s10434-021-10813.
    PubMed    
    Abstract available

  174. DIAMOND LM, Clarfield LE, Forte M
    Vaccinations against human papillomavirus missed because of COVID-19 may lead to a rise in preventable cervical cancer.
    CMAJ. 2021;193:E1467.
    PubMed    


  175. CHEN X, Ruan H, Ma Z, Hu J, et al
    Polymerase Chain Reaction in the Detection of miR-455-5p and Sphingosine-1 Phosphate Proteins in Cervical Carcinoma with the Help of Gold Nanoparticles-Based.
    J Biomed Nanotechnol. 2021;17:1535-1544.
    PubMed    
    Abstract available

  176. LU H, Wu Y, Liu X, Huang H, et al
    Endostar, an Anti-angiogenesis Inhibitor, Combined with Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Oncol Res. 2021 Sep 20. doi: 10.3727/096504021X16318716607908.
    PubMed    
    Abstract available

  177. PERKINS RB, Guido RS, Castle PE, Chelmow D, et al
    Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
    J Low Genit Tract Dis. 2021;25:330-331.
    PubMed    


  178. SHEU J, Field A, Viswanathan R, Minkowitz J, et al
    Prevalence of Positive Cervical Cancer Screening Tests Past the Age of 65 Years With Prior Adequate Negative Screening.
    J Low Genit Tract Dis. 2021;25:263-266.
    PubMed    
    Abstract available

  179. WANG W, Liu X, Wang D, Ren K, et al
    The 100 Most Cited Papers in Radiotherapy or Chemoradiotherapy for Cervical Cancer: 1990-2020.
    Front Oncol. 2021;11:642018.
    PubMed    
    Abstract available

  180. SYLER LB, Stobaugh CL, Foulis PR, Carlton GT, et al
    Cervical Cancer Screening in South Florida Veteran Population, 2014 to 2020: Cytology and High-Risk Human Papillomavirus Correlation and Epidemiology.
    Cureus. 2021;13:e17247.
    PubMed    
    Abstract available

  181. MARTINEZ-MORALES P, Moran Cruz I, Roa-de la Cruz L, Maycotte P, et al
    Hallmarks of glycogene expression and glycosylation pathways in squamous and adenocarcinoma cervical cancer.
    PeerJ. 2021;9:e12081.
    PubMed    
    Abstract available

  182. ARAKAKI Y, Shimoji Y, Nakasone T, Taira Y, et al
    Hyperbaric Oxygen Therapy for Suburethral Vaginal Mucosal Necrosis after Interstitial Irradiation for Recurrent Cervical Cancer.
    Case Rep Obstet Gynecol. 2021;2021:1737975.
    PubMed    
    Abstract available

  183. WANG Y, Xu B, Shen X, Sun L, et al
    Diagnostic value of miR-153 and miR-203 in patients with cervical cancer and their correlation with human papillomavirus infection.
    Am J Transl Res. 2021;13:9736-9742.
    PubMed    
    Abstract available

  184. MA Y, Kamalibaike M, Xin C, Li L, et al
    Effect of the intensive psychological nursing on adverse mood and quality of life in patients with cervical cancer.
    Am J Transl Res. 2021;13:9633-9638.
    PubMed    
    Abstract available

  185. ZHU X, Xiang Z, Zou L, Chen X, et al
    APMAP Promotes Epithelial-Mesenchymal Transition and Metastasis of Cervical Cancer Cells by Activating the Wnt/beta-catenin Pathway.
    J Cancer. 2021;12:6265-6273.
    PubMed    
    Abstract available

  186. ZHANG X, Zhang Y, Dou L
    miR-552 promotes the proliferation and metastasis of cervical cancer cells through targeting MUC15 pathway.
    J Cancer. 2021;12:6094-6104.
    PubMed    
    Abstract available

  187. CHEN X, Xu P, Zhang H, Su X, et al
    EGFR and ERK activation resists flavonoid quercetin-induced anticancer activities in human cervical cancer cells in vitro.
    Oncol Lett. 2021;22:754.
    PubMed    
    Abstract available

  188. QI C, He S, Cai L, Zhang L, et al
    A study on the clinical value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography combined with serum squamous cell carcinoma antigen in diagnosing recurrence/metastases in patients with early metaphase cervical cancer.
    Oncol Lett. 2021;22:746.
    PubMed    
    Abstract available

  189. ZHANG W, Liu J, Wu Q, Liu Y, et al
    HOTAIR Contributes to Stemness Acquisition of Cervical Cancer through Regulating miR-203 Interaction with ZEB1 on Epithelial-Mesenchymal Transition.
    J Oncol. 2021;2021:4190764.
    PubMed    
    Abstract available

  190. LI YX, Chang JY, He MY, Wang HR, et al
    Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer.
    J Oncol. 2021;2021:2939162.
    PubMed    
    Abstract available

  191. YU S, Li X, Zhang J, Wu S, et al
    Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer.
    Front Immunol. 2021;12:709493.
    PubMed    
    Abstract available

  192. MOUSAVI A, Modarres Gilani M, Akhavan S, Sheikh Hasani S, et al
    The Outcome of Locally Advanced Cervical Cancer in Patients Treated with Neoadjuvant Chemotherapy Followed by Radical Hysterectomy and Primary Surgery.
    Iran J Med Sci. 2021;46:355-363.
    PubMed    
    Abstract available

  193. ADEGBOYEGA A, Desmennu AT, Dignan M
    Qualitative assessment of attitudes toward cervical cancer (CC) screening and HPV self-sampling among African American (AA) and Sub Saharan African Immigrant (SAI) women.
    Ethn Health. 2021 Sep 19:1-18. doi: 10.1080/13557858.2021.1980771.
    PubMed    
    Abstract available

  194. KORNOVSKI Y, Ivanova Y, Kostov S, Slavchev S, et al
    GYNAECOLOGICAL ONCOLOGIC DISEASES AND PREGNANCY.
    Wiad Lek. 2021;74:1984-1987.
    PubMed    
    Abstract available

  195. ZHOU H, Wu P, Wu Y, Shi Y, et al
    Laparoscopic sphincter preserving total pelvic exenteration for recurrent cervical cancer - a video vignette.
    Colorectal Dis. 2021 Sep 18. doi: 10.1111/codi.15918.
    PubMed    
    Abstract available

  196. LI X, Wang L, Cui Z, Li Y, et al
    Online MR evaluation of inter- and intra-fraction uterus motions and bladder volume changes during cervical cancer external beam radiotherapy.
    Radiat Oncol. 2021;16:179.
    PubMed    
    Abstract available

  197. UNANYAN A, Pivazyan L, Davydova J, Murvatova K, et al
    Efficacy of photodynamic therapy in women with HSIL, LSIL and early stage squamous cervical cancer: a systematic review and meta-analysis.
    Photodiagnosis Photodyn Ther. 2021;36:102530.
    PubMed    
    Abstract available

  198. COLOMBO N, Dubot C, Lorusso D, Caceres MV, et al
    Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
    N Engl J Med. 2021 Sep 18. doi: 10.1056/NEJMoa2112435.
    PubMed    
    Abstract available

  199. CARNAHAN LR, Abdelrahim R, Ferrans CE, Rizzo GR, et al
    Rural Cancer Disparities: Understanding Implications for Breast and Cervical Cancer Diagnoses.
    Clin J Oncol Nurs. 2021;25:10-16.
    PubMed    
    Abstract available

  200. LIANG M, Li Y, Dai T, Chen C, et al
    lncRNA FEZF1-AS1 regulates biological behaviors of cervical cancer by targeting miRNA-1254.
    Food Sci Nutr. 2021;9:4722-4737.
    PubMed    
    Abstract available

  201. PARADKAR PH, Juvekar AS, Barkume MS, Amonkar AJ, et al
    In vitro and in vivo evaluation of a standardized haridra (Curcuma longa Linn) formulation in cervical cancer.
    J Ayurveda Integr Med. 2021 Sep 13. pii: S0975-9476(21)00110.
    PubMed    
    Abstract available

  202. CAI H, Feng Y, Fan P, Guo Y, et al
    HPV16 E6-specific T cell response and HLA-A alleles are related to the prognosis of patients with cervical cancer.
    Infect Agent Cancer. 2021;16:61.
    PubMed    
    Abstract available

  203. LI S, Han F, Qi N, Wen L, et al
    Determination of a six-gene prognostic model for cervical cancer based on WGCNA combined with LASSO and Cox-PH analysis.
    World J Surg Oncol. 2021;19:277.
    PubMed    
    Abstract available

  204. LI DJ, Shi J, Jin J, Du NY, et al
    [Epidemiological trend of cervical cancer].
    Zhonghua Zhong Liu Za Zhi. 2021;43:912-916.
    PubMed    
    Abstract available

  205. NAGASAWA S, Kasahara M, Aoki Y, Kusunoki S, et al
    Successful pregnancy with stage IB2 uterine cervical cancer: A case report.
    Cancer Rep (Hoboken). 2021 Sep 15:e1542. doi: 10.1002/cnr2.1542.
    PubMed    
    Abstract available

  206. DODD RH, Whop LJ, Smith MA
    Facilitating uptake of cervical screening among Indigenous women to achieve equitable and timely elimination of cervical cancer.
    Lancet Reg Health West Pac. 2021;13:100236.
    PubMed    


  207. JUWITASARI, Harini R, Rosyad AA
    Husband Support Mediates the Association between Self-Efficacy and Cervical Cancer Screening among Women in the Rural Area of Indonesia.
    Asia Pac J Oncol Nurs. 2021;8:560-564.
    PubMed    
    Abstract available

  208. MUREWANHEMA G
    The COVID-19 pandemic and its implications for cervical cancer treatment and prevention in Zimbabwe: perspectives and recommendations.
    Pan Afr Med J. 2021;39:149.
    PubMed    
    Abstract available


  209. Long Noncoding RNA SNHG7, a Molecular Sponge for microRNA-485, Promotes the Aggressive Behavior of Cervical Cancer by Regulating PAK4 [Retraction].
    Onco Targets Ther. 2021;14:4741-4742.
    PubMed    
    Abstract available

  210. YE J, Chen X, Lu W
    Identification and Experimental Validation of Immune-Associate lncRNAs for Predicting Prognosis in Cervical Cancer.
    Onco Targets Ther. 2021;14:4721-4734.
    PubMed    
    Abstract available

  211. CASTANON A, Kamineni A, Elfstrom KM, Lim AW, et al
    Exposure definition in case-control studies of cervical cancer screening: a systematic literature review.
    Cancer Epidemiol Biomarkers Prev. 2021 Sep 14. pii: 1055-9965.EPI-21-0376.
    PubMed    
    Abstract available

  212. SASAKI Y, Kemuriyama K, Sasaki S, Orino K, et al
    [A Case of Malignant Lymphoma of the Ileum and Uterine Cervix with Perforating Peritonitis of Ileum Tumor Detected during Chemotherapy].
    Gan To Kagaku Ryoho. 2021;48:1157-1159.
    PubMed    
    Abstract available

  213. BANERJEE S, Sandhu M, Tonzi E, Tambe A, et al
    Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine.
    Am J Ther. 2021;28:e604-e606.
    PubMed    


  214. ADJEI BA, White DP, McCarthy S, Priede LM, et al
    Opportunities for Cancer Health Care Disparities and Care Delivery Research: An Analysis of the NCI Health Care Delivery Research Program Portfolio.
    J Health Care Poor Underserved. 2021;32:1475-1492.
    PubMed    
    Abstract available

  215. KIM M, Park NJ, Jeong JY, Park JY, et al
    Multiple Human Papilloma Virus (HPV) Infections Are Associated with HSIL and Persistent HPV Infection Status in Korean Patients.
    Viruses. 2021;13.
    PubMed    
    Abstract available

  216. GILLES C, Velghe-Lenelle M, Manigart Y, Konopnicki D, et al
    Should the management of high grade cervical squamous intraepithelial lesion (HSIL) be different in HIV-positive women?
    AIDS Res Ther. 2021;18:44.
    PubMed    
    Abstract available

  217. WANG X, Cao A, Hou Z, Li X, et al
    Identification of key classification features of early cervical squamous cell carcinoma.
    Comput Biol Chem. 2021;93:107531.
    PubMed    
    Abstract available

  218. GOULD HJ 3RD, Miller PR, Edenfield S, Sherman KJ, et al
    Emergency Use of Targeted Osmotic Lysis for the Treatment of a Patient with Aggressive Late-Stage Squamous Cell Carcinoma of the Cervix.
    Curr Oncol. 2021;28:2115-2122.
    PubMed    
    Abstract available

  219. ZHANG L, Zhang J, Liu Y, Zhang P, et al
    Mitochondrial STAT5A promotes metabolic remodeling and the Warburg effect by inactivating the pyruvate dehydrogenase complex.
    Cell Death Dis. 2021;12:634.
    PubMed    
    Abstract available

  220. BRYANT J, Patterson K, Vaska M, Chiang B, et al
    Cancer Screening Interventions in Indigenous Populations: A Rapid Review.
    Curr Oncol. 2021;28:1728-1743.
    PubMed    
    Abstract available

  221. BERNER AM, Connolly DJ, Pinnell I, Wolton A, et al
    Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK.
    Br J Gen Pract. 2021;71:e614-e625.
    PubMed    
    Abstract available

  222. PARK JY, Lee YH, Chong GO, Hong DG, et al
    A uterine cervix supporting device (Con-CapTM) for reducing canal stenosis after Loop Electrosurgical Excisional Procedure.
    Technol Health Care. 2021;29:955-962.
    PubMed    
    Abstract available

  223. GAY J, Johnson N, Kavuru V, Phillips M, et al
    Utility of the Human Papillomavirus Vaccination in Management of HPV-associated Cutaneous Lesions.
    Skin Therapy Lett. 2021;26:6-8.
    PubMed    
    Abstract available

  224. WANG H, Ni C, Xiao W, Yang T, et al
    Comparison of Radical Surgery and Radiotherapy for the Treatment of Early-Stage Cervical Carcinoma: A Meta-Analysis.
    Oncol Res Treat. 2021;44:176-183.
    PubMed    
    Abstract available

  225. SINGH N, Rabban JT
    The ISGyP Endocervical Adenocarcinoma Project: Master Plan Summary, Acknowledgment of Participants, and Participant Responses to Final Recommendations of the Expert Panels.
    Int J Gynecol Pathol. 2021;40 Suppl 1:S111-S123.
    PubMed    
    Abstract available

  226. MCCLUGGAGE WG, Rabban JT, Singh N, Oliva E, et al
    Survey Results on Pathologic Aspects of Endocervical Adenocarcinoma by the International Society of Gynecological Pathologists.
    Int J Gynecol Pathol. 2021;40 Suppl 1:S4-S13.
    PubMed    
    Abstract available

  227. KAWAHARA R, Fujii T, Kukimoto I, Nomura H, et al
    Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia.
    Sci Rep. 2021;11:2156.
    PubMed    
    Abstract available

  228. WILSON LA, Quan AML, Bota AB, Mithani SS, et al
    Newcomer knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination.
    BMC Fam Pract. 2021;22:17.
    PubMed    
    Abstract available

  229. BAISLEY KJ, Whitworth HS, Changalucha J, Pinto L, et al
    A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) - Study protocol for a randomised controlled trial.
    Contemp Clin Trials. 2021;101:106266.
    PubMed    
    Abstract available

  230. DEVINE K, Mitchell AL
    Cervical screening in women with classic congenital adrenal hyperplasia: uptake and barriers.
    BMJ Sex Reprod Health. 2021;47:153-154.
    PubMed    


  231. LIU X, Gao J, Wang J, Chu J, et al
    Identification of two molecular subtypes of dysregulated immune lncRNAs in ovarian cancer.
    Exp Biol Med (Maywood). 2021;246:547-559.
    PubMed    
    Abstract available

  232. LIN Y, He L, Mei Y
    A new technique of laparoscopic para-aortic lymphadenectomy optimizes perioperative outcome.
    J Gynecol Oncol. 2021;32:e2.
    PubMed    
    Abstract available

  233. COLOMBO PE, Nguyen VH, Taoum C, Mourregot A, et al
    Robotic Radical Hysterectomy for Cervical Adenocarcinoma after Preoperative Brachytherapy in 10 Steps.
    J Minim Invasive Gynecol. 2021;28:1138-1139.
    PubMed    
    Abstract available

  234. MOGHTADERI A, Dor A
    Immunization and Moral Hazard: The HPV Vaccine and Uptake of Cancer Screening.
    Med Care Res Rev. 2021;78:125-137.
    PubMed    
    Abstract available

  235. LEW M, Wilbur DC, Pantanowitz L
    Computational Cytology: Lessons Learned from Pap Test Computer-Assisted Screening.
    Acta Cytol. 2021;65:286-300.
    PubMed    
    Abstract available

  236. GUO Y, Peng Q, Wang Y, Li L, et al
    The Application of DNA Ploidy Analysis in Large-Scale Population Screening for Cervical Cancer.
    Acta Cytol. 2021;65:385-392.
    PubMed    
    Abstract available

  237. FEINBERG T, Yehuda-Shnaidman E, Wolf T, Sandbank J, et al
    HPV Screening Test for the Detection of Precancerous Cervical Lesions and Cervical Cancer in Israeli Women.
    Acta Cytol. 2021 Aug 24:1-7. doi: 10.1159/000518324.
    PubMed    
    Abstract available

  238. PUJARI R, Newman MR, Talia KL, Pendlebury A, et al
    Seborrheic Keratosis-Like Lesion of the Cervix: First Report of the Cytological Features of a Low-Risk HPV 42-Associated Lesion.
    Acta Cytol. 2021;65:448-452.
    PubMed    
    Abstract available

  239. IDEN M, Tsaih SW, Huang YW, Liu P, et al
    Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes.
    Br J Cancer. 2021 Sep 15. pii: 10.1038/s41416-021-01545.
    PubMed    
    Abstract available

  240. NIERENGARTEN MB
    Study shows a decrease in cervical cancer but a rise in other human papillomavirus-related cancers.
    Cancer. 2021;127:3499.
    PubMed    


  241. OLAFSDOTTIR T, Stacey SN, Sveinbjornsson G, Thorleifsson G, et al
    Loss-of-Function Variants in the Tumor-Suppressor Gene PTPN14 Confer Increased Cancer Risk.
    Cancer Res. 2021;81:1954-1964.
    PubMed    
    Abstract available

  242. ESCAMILLA GALINDO EP, Medina Ramos NF, Santana Mateo YL, Armas Roca M, et al
    Post-Conization FIGO stage IA1 squamous cell cervical carcinoma; is hysterectomy necessary?
    Eur J Obstet Gynecol Reprod Biol. 2021;264:368-373.
    PubMed    
    Abstract available

  243. CHILAKA VN, Navti OB, Al Beloushi M, Ahmed B, et al
    Human papillomavirus (HPV) in pregnancy - An update.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:340-348.
    PubMed    
    Abstract available

  244. MATANES E, Linder R, Lauterbach R, Mick I, et al
    The impact of radiation therapy on vaginal biomechanical properties.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:36-40.
    PubMed    
    Abstract available

  245. MATZ M, Weir HK, Alkhalawi E, Coleman MP, et al
    Disparities in cervical cancer survival in the United States by race and stage at diagnosis: An analysis of 138,883 women diagnosed between 2001 and 2014 (CONCORD-3).
    Gynecol Oncol. 2021 Aug 25. pii: S0090-8258(21)01312.
    PubMed    
    Abstract available

  246. VENKAT P, Salani R
    Changing paradigms in intermediate-risk cervical cancer: Sedlis revisited.
    Gynecol Oncol. 2021;162:527-528.
    PubMed    


  247. O'MALLEY DM, Oaknin A, Monk BJ, Selle F, et al
    Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer.
    Gynecol Oncol. 2021 Aug 24. pii: S0090-8258(21)01316.
    PubMed    
    Abstract available

  248. LUHRS O, Ekdahl L, Geppert B, Lonnerfors C, et al
    Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancer.
    Gynecol Oncol. 2021 Sep 8. pii: S0090-8258(21)01328.
    PubMed    
    Abstract available

  249. QIN J, Shahangian S, Saraiya M, Holt H, et al
    Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.
    Gynecol Oncol. 2021 Sep 7. pii: S0090-8258(21)01321.
    PubMed    
    Abstract available

  250. WU S, Ding X, Kong Y, Acharya S, et al
    The feature of cervical microbiota associated with the progression of cervical cancer among reproductive females.
    Gynecol Oncol. 2021 Sep 6. pii: S0090-8258(21)01314.
    PubMed    
    Abstract available

  251. SPONHOLTZ SE, Mogensen O, Hildebrandt MG, Schledermann D, et al
    From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups?
    Gynecol Oncol. 2021 Sep 6. pii: S0090-8258(21)01324.
    PubMed    
    Abstract available

  252. DODD RH, Cvejic E, Bell K, Black K, et al
    Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental study.
    Gynecol Oncol. 2021;161:179-187.
    PubMed    
    Abstract available

  253. BOGANI G, Sopracordevole F, Di Donato V, Ciavattini A, et al
    High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes.
    Gynecol Oncol. 2021 Jan 26. pii: S0090-8258(21)00080.
    PubMed    
    Abstract available

  254. CASTLE PE, Locke A, Tergas AI, Befano B, et al
    The relationship of human papillomavirus and cytology co-testing results with endometrial and ovarian cancer diagnoses.
    Gynecol Oncol. 2021 Jan 13. pii: S0090-8258(21)00052.
    PubMed    
    Abstract available

  255. KANAO H, Aoki Y, Omi M, Nomura H, et al
    Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome.
    Gynecol Oncol. 2021 Jan 7. pii: S0090-8258(20)34249.
    PubMed    
    Abstract available

  256. SALTA S, Maia-Moco L, Estevao-Pereira H, Sequeira JP, et al
    Performance of DNA methylation-based biomarkers in the Cervical Cancer Screening Program of Northern Portugal: a feasibility study.
    Int J Cancer. 2021 Aug 30. doi: 10.1002/ijc.33778.
    PubMed    
    Abstract available

  257. JAYARAJ R, Shaw P, Kumarasamy C, Shetty SS, et al
    Comments on "Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis".
    Int J Cancer. 2021;148:2857-2858.
    PubMed    


  258. MALAGON T, Volesky KD, Franco EL
    Reply to: Comments on cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis.
    Int J Cancer. 2021;148:2859-2860.
    PubMed    


  259. BUDUKH A, Dikshit R, Chaturvedi P
    Outcome of the randomized control screening trials on Oral, Cervix and Breast Cancer from India and way forward in COVID-19 pandemic situation.
    Int J Cancer. 2021 Jun 21. doi: 10.1002/ijc.33712.
    PubMed    


  260. HOPPE-SEYLER K, Herrmann AL, Daschle A, Kuhn BJ, et al
    Effects of Metformin on the virus/host cell crosstalk in HPV-positive cancer cells.
    Int J Cancer. 2021 Apr 12. doi: 10.1002/ijc.33594.
    PubMed    


  261. VINK FJ, Dick S, Heideman DAM, De Strooper LMA, et al
    Classification of high-grade CIN by p16(ink4a) , Ki-67, HPV E4 and FAM19A4/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for management.
    Int J Cancer. 2021 Mar 17. doi: 10.1002/ijc.33566.
    PubMed    
    Abstract available

  262. DONKEN R, van Niekerk D, Hamm J, Spinelli JJ, et al
    Declining Rates of Cervical Intraepithelial Neoplasia in British Columbia, Canada: An Ecological Analysis On The Effects of The School-Based HPV Vaccination Program.
    Int J Cancer. 2021 Feb 14. doi: 10.1002/ijc.33513.
    PubMed    


  263. KITAZAWA S, Takaoka Y, Ueda Y, Kitazawa R, et al
    Identification of Calmodulin-Like Protein 5 (CALML5) as tumor-suppressor gene silenced during early stage of carcinogenesis in squamous cell carcinoma of uterine cervix.
    Int J Cancer. 2021 May 17. doi: 10.1002/ijc.33687.
    PubMed    
    Abstract available

  264. DICK A, Holyk T, Taylor D, Wenninger C, et al
    Highlighting strengths and resources that increase ownership of cervical cancer screening for Indigenous communities in Northern British Columbia: Community-driven approaches.
    Int J Gynaecol Obstet. 2021 Sep 8. doi: 10.1002/ijgo.13915.
    PubMed    
    Abstract available

  265. SCHMELER KM, Pareja R, Lopez Blanco A, Humberto Fregnani J, et al
    ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer.
    Int J Gynecol Cancer. 2021 Sep 7. pii: ijgc-2021-002921.
    PubMed    
    Abstract available

  266. KIRCHHEINER K, Smet S, Jurgenliemk-Schulz IM, Haie-Meder C, et al
    Impact of vaginal symptoms and hormonal replacement therapy on sexual outcomes in locally advanced cervical cancer patients after definitive chemoradiotherapy - results from the EMBRACE-I study.
    Int J Radiat Oncol Biol Phys. 2021 Aug 31. pii: S0360-3016(21)02729.
    PubMed    
    Abstract available

  267. DAMAST S, Fields E, Kidd E, Harkenrider M, et al
    Reports From Four International Clinical Trials for Cancers of the Cervix, Uterus and Vulva, and a New Guideline for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111:299-306.
    PubMed    


  268. CUSCHIERI K, Wilson A, Palmer T, Stanczuk G, et al
    The challenges of defining sample adequacy in an era of HPV based cervical screening.
    J Clin Virol. 2021;137:104756.
    PubMed    
    Abstract available

  269. PETERS M, de Leeuw AAC, Nomden CN, Tanderup K, et al
    Risk factors for nodal failure after radiochemotherapy and image-guided brachytherapy in locally advanced cervical cancer: an EMBRACE analysis.
    Radiother Oncol. 2021 Sep 1. pii: S0167-8140(21)06714.
    PubMed    
    Abstract available

  270. CORBEAU A, Kuipers SC, de Boer SM, Horeweg N, et al
    Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review.
    Radiother Oncol. 2021 Sep 21. pii: S0167-8140(21)06732.
    PubMed    
    Abstract available

  271. LIU J, Liu X, Guo Z, Lv X, et al
    Ultrasound-guided fine needle aspiration cytology of Para-aortic lymph node metastasis in uterine cervical cancer: diagnostic accuracy and impact on clinical decision making.
    BMC Cancer. 2021;21:964.
    PubMed    
    Abstract available

  272. YANG J, Yan Z, Wang Y, Xu J, et al
    Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
    BMC Cancer. 2021;21:997.
    PubMed    
    Abstract available

  273. DESTAW A, Midaksa M, Addissie A, Kantelhardt EJ, et al
    Cervical cancer screening "see and treat approach": real-life uptake after invitation and associated factors at health facilities in Gondar, Northwest Ethiopia.
    BMC Cancer. 2021;21:1031.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;